Chronic fluoxetine induces changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain

被引:99
作者
Castro, ME [1 ]
Diaz, A [1 ]
del Olmo, E [1 ]
Pazos, A [1 ]
机构
[1] Univ Cantabria, Sch Med, Dept Physiol & Pharmacol, Santander 39011, Cantabria, Spain
关键词
S-35]GTP gamma S autoradiography; 5-HT1A receptors; fluoxetine; G proteins;
D O I
10.1016/S0028-3908(02)00340-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Chronic treatment with the antidepressant fluoxetine may lead to changes in the properties of pre- and postsynaptic 5-HT1A receptors due to modifications in the receptor-G protein coupling process. We have evaluated, in rats, the effect of chronic fluoxetine (10 mg/kg/day) at brain 5-HT1A receptors using different techniques. The density of 5-HT1A receptors was unchanged in fluoxetine treated rats vs. vehicle group. Stimulation of [S-35]GTPgammaS binding induced by (+/-)8-OH-DPAT was significantly attenuated in dorsal raphe nucleus after fluoxetine (+3.7 vs. +31.2% in vehicle). The inhibition of dorsal raphe firing by (+/-)8-OH-DPAT (ED50 in vehicle = 2.1 mug/kg, i.v.) was also attenuated in rats treated with fluoxetine (ED50 = 4.7 mug/kg). In contrast, a significant increase on (+/-)8-OH-DPAT-induced stimulation of [S-35]GTPgammaS binding was observed in CA(1) (+53.4 vs.+20.2% in vehicle) and dentate gyrus (+105.7 vs. +52.6% in vehicle) but not in entorhinal cortex. Our data demonstrate that fluoxetine-induced desensitization of 5-HT1A autoreceptors occurs at G protein level. Moreover, a relevant finding is the region-specific hypersensitivity of postsynaptic 5-HT1A receptors, in the hippocampus but not in entorhinal cortex, following chronic fluoxetine. These differential adaptive changes in brain 5-HT1A receptors could underlie the mechanism of action of antidepressants and also contribute to their clinical effects. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:93 / 101
页数:9
相关论文
共 42 条
[1]   ELECTROPHYSIOLOGY OF THE CENTRAL SEROTONIN SYSTEM - RECEPTOR SUBTYPES AND TRANSDUCER MECHANISMS [J].
AGHAJANIAN, GK ;
SPROUSE, JS ;
SHELDON, P ;
RASMUSSEN, K .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 600 :93-103
[2]  
AGHAJANIAN GK, 1970, J PHARMACOL EXP THER, V171, P178
[3]   A-G PROTEIN COUPLES SEROTONIN AND GABA-B RECEPTORS TO THE SAME CHANNELS IN HIPPOCAMPUS [J].
ANDRADE, R ;
MALENKA, RC ;
NICOLL, RA .
SCIENCE, 1986, 234 (4781) :1261-1265
[4]   Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims [J].
Arango, V ;
Underwood, MD ;
Boldrini, M ;
Tamir, H ;
Kassir, SA ;
Hsiung, SC ;
Chen, JJX ;
Mann, JJ .
NEUROPSYCHOPHARMACOLOGY, 2001, 25 (06) :892-903
[5]   A review of central 5-HT receptors and their function [J].
Barnes, NM ;
Sharp, T .
NEUROPHARMACOLOGY, 1999, 38 (08) :1083-1152
[6]  
BECK SG, 1997, J PHARM EXPT THERAPE, V218, P115
[7]   CHRONIC TREATMENT WITH FLUVOXAMINE INCREASES EXTRACELLULAR SEROTONIN IN FRONTAL-CORTEX BUT NOT IN RAPHE NUCLEI [J].
BEL, N ;
ARTIGAS, F .
SYNAPSE, 1993, 15 (03) :243-245
[8]   CURRENT ADVANCES AND TRENDS IN THE TREATMENT OF DEPRESSION [J].
BLIER, P ;
DEMONTIGNY, C .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (07) :220-226
[9]  
CADOGAN AK, 1994, J NEUROCHEM, V62, P1816
[10]  
CASTRO E, 2001, ABSTR SOC NEUROSCI, V27, P380